NEXT-ChemX Corporation. (CHMX) Financial Statements (2024 and earlier)

Company Profile

Business Address 901 MOPAC EXPRESSWAY SOUTH BUILDING 1
AUSTIN, TX 78746
State of Incorp. NV
Fiscal Year End December 31
Industry (SIC) 289 - Miscellaneous Chemical Products (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1591422805318
Cash and cash equivalents581422805318
Short-term investments102     
Prepaid expense  2    
Other undisclosed current assets731222322
Total current assets:2321565135420
Noncurrent Assets
Property, plant and equipment151718192120
Intangible assets, net (including goodwill)3,1503,1503,1503,1503,1503,150
Intangible assets, net (excluding goodwill)3,1503,1503,1503,1503,1503,150
Total noncurrent assets:3,1653,1673,1683,1693,1713,170
TOTAL ASSETS:3,3983,3223,2193,1723,2253,190
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1,8681,6791,5491,4951,2781,054
Accrued liabilities3451,150    
Other undisclosed accounts payable and accrued liabilities1,5235301,5491,4951,2781,054
Debt50275926674649 
Due to related parties  2118
Other liabilities5121212   
Other undisclosed current liabilities592582 1515693
Total current liabilities:3,0222,5482,4872,1841,9431,865
Noncurrent Liabilities
Total liabilities:3,0222,5482,4872,1841,9431,865
Equity
Equity, attributable to parent, including:3767747329891,2821,325
Common stock282828282827
Additional paid in capital4,8964,8964,3964,1534,0453,634
Accumulated deficit(4,548)(4,151)(3,693)(3,193)(2,791)(2,337)
Other undisclosed equity, attributable to parent   (0)   
Total equity:3767747329891,2821,325
TOTAL LIABILITIES AND EQUITY:3,3983,3223,2193,1723,2253,190

Income Statement (P&L) ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Revenues 500     
Gross profit: 500     
Operating expenses(582)(437)(473)(388)(438)(374)
Other undisclosed operating loss (500)     
Operating loss:(582)(437)(473)(388)(438)(374)
Nonoperating income (expense)184(21)(27)(14)(16)(14)
Other nonoperating income (expense)203     
Interest and debt expense(19)(21)(27)(14)(16)(14)
Loss from continuing operations before equity method investments, income taxes:(417)(479)(527)(415)(471)(402)
Other undisclosed income from continuing operations before income taxes   71   
Loss from continuing operations:(417)(479)(456)(415)(471)(402)
Loss before gain (loss) on sale of properties:(415)(471)(402)
Net loss:(417)(479)(456)(415)(471)(402)
Other undisclosed net income (loss) attributable to parent1921(44)141614
Net loss available to common stockholders, diluted:(398)(458)(500)(401)(455)(388)

Comprehensive Income ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Net loss:(417)(479)(456)(415)(471)(402)
Comprehensive loss, net of tax, attributable to parent:(417)(479)(456)(415)(471)(402)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: